There’s a little-known company we’ve been tracking for a while now—a turnaround story that’s been quietly grinding through operational changes, product rollouts, and a broader reinvention of its brand identity. It’s not the kind of name you’ll hear pitched by even other microcap investors, but recent developments in a new supplement market it recently entered just made this stock a lot more interesting for investors who appreciate the power of information arbitrage.